FatiAbGen is a leading antibody engineering company leveraging collaborations across the global biotech ecosystem to deverlop best-in-class therapeuties for high unmet need oncology and immunology conditions. 

FatiAbGen has a strong global view with passion. FatiAbGen is the first Korean company to be a member of Shonan iPark, the largest biotech cluster in Japan. 

FatiAbGen became a member of the JLABS family in 2023, strongly aligned with J&J’s innovative portfolio. 

In 2024, FatiAbGen established a new subsidiary in Basel Switzerland to accelerate business development for future out-licensing. 

Biotechnology

FatiAbGen Inc.

Org chart

Teams

Offices

Similar companies